Dr. Teitelbaum is an internationally recognized board-certified plastic surgeon known for his expertise in breast augmentation. He has extensive experience working with both saline and silicone implants, having helped design and test the most current models, and he lectures and teaches other surgeons how to perform breast augmentation surgery and achieve the best results with minimal pain and recovery time.
Does the idea of a virtually pain-free breast augmentation seem too good to be true?
Many of Dr. Teitelbaum’s patients chose him to be their surgeon because of his expertise with cohesive gel implants (also known as “gummy-bear implants” because the gel has a consistency similar to that of the candy). While used globally since 1993, they are not yet approved by the FDA and are only available to patients participating in clinical trials.
Every woman considering breast augmentation shares the same concern: How do I choose an implant that’s the right size for me?
Decisions about implant type, size, incision, and pocket location will have a permanent effect on your breasts. Too often these decisions are based upon “patient choice” or “surgeon preference,” rather than the conclusions of the best scientific articles.
Dr. Teitelbaum’s approach to breast augmentation is a direct result of years of studying, writing, and lecturing on the subject. He’d like to share with you a few of the points that distinguish him from other aesthetic surgeons.
Known simply as the CPG, Mentor's cohesive gel filled implant is becoming increasingly popular.
Recovering from breast augmentation generally involves two to three weeks of pain and stiffness. But now a new version of the operation that promises a 24-hour recovery is increasingly in demand.
Dr. Teitelbaum is an authority in the field of cohesive gel breast implants, and has lectured about them to other plastic surgeons.
Plastic Surgeon Steven Teitelbaum, M.D., FACS, and Dermatologist Karyn L. Grossman, MD, find success in the power of two.
Dr. Teitelbaum is pleased to announce new enrollment opportunities for patients interested in receiving the Allergan Style 410 implant.
Only about 30 surgeons participated in the initial FDA approved core clinical study of 960 patients, which took place in 2001 and 2002.